I2o Therapeutics

Provider of an oral drug delivery solution

placeBoston, Massachusetts, United States calendar_todayFounded 2019 groups6 employees language i2obio.com

Registered entities

Investor mix

7 investors on record; lead investors include Sanofi Ventures, T1D Fund, Colorcon.

Investor typeCountShare
Venture capital686%
Other / undisclosed114%
Coming soon